Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ARGENX | 4 | 10 | +0,95 % | ||
 | UMICORE | 1 | 2 | +2,99 % | |
| SYENSQO | 1 | 1 | -0,18 % | |
| AB INBEV | - | 30 | +0,31 % | |
| MELEXIS | - | 4 | +0,16 % | |
| ELIA GROUP | - | 4 | 0,00 % | |
| AGEAS | - | 1 | -1,02 % | |
| KBC GROEP NV | - | 1 | -1,23 % | |
| GBL | - | 1 | -0,96 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18:36 | Umicore: Transparency notification by JP Morgan Asset Management Holdings Inc. | 9 | GlobeNewswire (USA) | ||
| 15:42 | argenx stock price target maintained at $800 by TD Cowen on strong Vyvgart uptake | 3 | Investing.com | ||
| 15:26 | Should You Be Confident in Argenx SE' (ARGX) Long-Term Profit Cycle? | 10 | Insider Monkey | ||
| 12:05 | ARGENX SE - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 07:06 | argenx SE: argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session | 8 | GlobeNewswire (USA) | ||
| 03:06 | Syensqo Q2 2025 slides: sequential margin growth amid challenging macro environment | 1 | Investing.com | ||
| Di | Cofinimmo H1 2025 slides: Healthcare portfolio drives earnings growth amid strategic shift | 2 | Investing.com | ||
| Di | Dividendenbekanntmachungen (14.10.2025) | 3.503 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) BANK OZK US06417N1037 0,45 USD 0,3888 EUR COCA-COLA FEMSA SAB DE CV ADR US1912411089 1,0005 USD 0,8645 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen | |
| Di | Syensqo launches portfolio of elastomers and lubricants fluids with certified circular content | 1 | Hydrocarbon Engineering | ||
| Di | Finanzierungen: Eurogrid, Ottobock, SHS | 31 | Finance Magazin | ||
| Di | Belgium's Syensqo unveils certified circular elastomers & lubricants | 1 | fibre2fashion | ||
| Di | Syensqo SA: Participation notification by Capital Group Companies Inc. | 179 | GlobeNewswire (Europe) | Press release (https://www.syensqo.com/en/newsroom/news-and-press-releases)
Communiqué de presse (https://www.syensqo.com/en/newsroom/news-and-press-releases)
Persbericht... ► Artikel lesen | |
| Di | Berenberg hebt Kursziel für UCB wegen starkem Bimzelx-Wachstum auf 290 Euro an | 6 | Investing.com Deutsch | ||
| Di | Berenberg raises UCB stock price target to EUR290 on strong Bimzelx growth | 1 | Investing.com | ||
| Mo | UCB Announces Promising Study Results For Investigational TK2 Deficiency Therapy | 322 | AFX News | BRUSSELS (dpa-AFX) - According to results from a multicenter study published by Neurology, UCB SA (UCBJY) showed on Monday, that its investigational pyrimidine nucleoside therapy has the potential... ► Artikel lesen | |
| Mo | ClearBridge International Growth shifts bank holdings, adds Santander, HSBC, KBC; exits BBVA and HDFC | 24 | Seeking Alpha | ||
| Mo | GBL: GBL - Transactions on GBL shares 13-10-2025 | 1 | Euronext | ||
| Mo | Syensqo SA: Acquisition of own shares | 164 | GlobeNewswire (Europe) | Press release (https://www.syensqo.com/en/newsroom/news-and-press-releases)
Communiqué de presse (https://www.syensqo.com/en/newsroom/news-and-press-releases)
Persbericht... ► Artikel lesen | |
| Mo | UCB drug for rare disease TK2d boosts survival | 2 | pharmaphorum | ||
| Mo | Swedish survey specialist nets contract with 50Hertz | 1 | Offshore Energy Today |
1 2 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .